Bifogade filer
PDF
Kurs
+18,60%
Likviditet
0,01 MSEK
Kalender
| Tid* | ||
| 2025-02-21 | 08:30 | Bokslutskommuniké 2024 |
| 2024-08-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-19 | - | Årsstämma |
| 2024-04-19 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2024-02-23 | - | Bokslutskommuniké 2023 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-20 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2023-04-19 | - | Årsstämma |
| 2023-02-24 | - | Bokslutskommuniké 2022 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-08-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-08-17 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-10 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2022-04-20 | - | Årsstämma |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-04 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2021-06-03 | - | Årsstämma |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-08-25 | - | Kvartalsrapport 2020-Q2 |
| 2020-02-27 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2020-02-26 | - | Årsstämma |
| 2020-02-04 | - | Bokslutskommuniké 2019 |
| 2019-05-08 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2019-05-07 | - | Årsstämma |
| 2019-02-22 | - | Bokslutskommuniké 2018 |
| 2018-08-10 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-03 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2018-05-02 | - | Årsstämma |
| 2018-02-23 | - | Bokslutskommuniké 2017 |
| 2017-08-11 | - | Kvartalsrapport 2017-Q2 |
| 2017-03-21 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2017-03-20 | - | Årsstämma |
| 2017-02-17 | - | Bokslutskommuniké 2016 |
| 2016-11-04 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-04 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-04 | - | X-dag ordinarie utdelning CLINE B 0.00 SEK |
| 2016-05-03 | - | Kvartalsrapport 2016-Q1 |
| 2015-11-06 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-06 | - | Kvartalsrapport 2015-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Cline Scientific is one of the companies included in Medtech4Health's capacity building program, to enable the strategy and regulatory pathway for StemCART.
Medtech4Health's call Strengthening skills in small businesses gives companies the opportunity to hire an external person during the project period. The aim is to help the company develop and market an innovative medical technology solution. Read more about the companies included here: https://medtech4health.se/atta-nya-projekt-starker-sin-kompetens-tack-vare-medtech4health/.
Medtech4Health strive to increase the number and quality of new innovative products and services within medtech. In collaboration with patients, healthcare, academia, and business, we contribute to increasing value for people affected by disease in their everyday lives. Medtech4Health is funded by the Swedish government through the Swedish innovation authority Vinnova, Swedish Energy Agency and Swedish Research Council for Sustainable Development Formas, and by the programme's partners.
For more information, please contact:
Hanne Evenbratt, VP Research & Development
Email: hanne.evenbratt@clinescientific.com
Phone: +46 704 88 79 23
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 0703585088
Argongatan 2 C Email: info@clinescientific.com
431 53 MÖLNDAL Website: www.clinescientific.com